COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • October 3rd, 2013 • Celgene Corp /De/ • Pharmaceutical preparations • Massachusetts
Contract Type FiledOctober 3rd, 2013 Company Industry JurisdictionTHIS COMMON STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of September 24, 2013 by and between Acceleron Pharma Inc., a Delaware corporation (the “Corporation”) and Celgene Corporation, a Delaware corporation (“Celgene”).
REGISTRATION RIGHTS AGREEMENT (AMENDED AND RESTATED AS OF DECEMBER 22, 2011)Registration Rights Agreement • October 3rd, 2013 • Celgene Corp /De/ • Pharmaceutical preparations • Massachusetts
Contract Type FiledOctober 3rd, 2013 Company Industry JurisdictionThis Amended and Restated Registration Rights Agreement (this “Agreement”) is made as of December 22, 2011 by and among Acceleron Pharma Inc., a Delaware corporation (the “Corporation”) and the parties listed on Exhibit A hereto (the “Investors”).
SERIES E CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENTSeries E Convertible Preferred Stock • October 3rd, 2013 • Celgene Corp /De/ • Pharmaceutical preparations • Massachusetts
Contract Type FiledOctober 3rd, 2013 Company Industry JurisdictionTHIS SERIES E CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (“Agreement”) is made as of June 10, 2010 by and among Acceleron Pharma Inc., a Delaware corporation (the “Corporation”) and the investors that are named on the Initial Closing Schedule of Investors and Additional Closing Schedule of Investors attached hereto (the “Investors”).
SERIES C-1 CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTConvertible Preferred Stock Purchase Agreement • October 3rd, 2013 • Celgene Corp /De/ • Pharmaceutical preparations • Massachusetts
Contract Type FiledOctober 3rd, 2013 Company Industry JurisdictionTHIS SERIES C-1 CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (“Agreement”) is made as of February 20, 2008 (the “Execution Date”) by and among Acceleron Pharma Inc., a Delaware corporation (the “Corporation”) and Celgene Corporation, a Delaware corporation (the “Investor”).
SERIES F CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTSeries F Convertible Preferred Stock • October 3rd, 2013 • Celgene Corp /De/ • Pharmaceutical preparations • Massachusetts
Contract Type FiledOctober 3rd, 2013 Company Industry JurisdictionTHIS SERIES F CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (“Agreement”) is made as of December 22, 2011 by and among Acceleron Pharma Inc., a Delaware corporation (the “Corporation”) and the investors that are named on the Schedule of Investors attached hereto (the “Investors”).